Screening for inherited breast and ovarian cancer susceptibility is a two-step process that includes an assessment of risk for clinically significant BRCA mutations followed by genetic testing of high-risk individuals. The evidence synthesis describes the strengths and limits of evidence about the effectiveness of selecting, testing, and managing patients in the course of screening in the primary care setting. Its objective is to determine the ba...
De Genetic Risk Assessment and Brca Mutation Testing for Breast and Ovarian Cancer Susceptibility is een populaire optie voor Medisch onderzoek. Esy heeft 1 prijs gevonden, de goedkoopste keuze is volgens ons Bol, maar bekijk de andere aanbieders om het zeker te weten. Links openen in een nieuwe tabblad. Bekijk hier onder de product specificaties. Meer product informatie beschikbaar bij Bol.
Genetic Risk Assessment and Brca Mutation Testing for Breast and Ovarian Cancer Susceptibility is onder andere te koop bij: Bol. Esy raadt altijd aan om meerdere aanbieders te bekijken om geen last minute deals mis te lopen.
Modern analytical biotechnology is focused on the use of a set of enabling platform technologies that provide contemporary, state-of-the-art tools for genomics, proteomics, metabolomics, drug discover...